Literature DB >> 34290820

Osmotic Demyelination Syndrome Associated with Hypernatremia Caused by Lactulose Enema in a Patient with Chronic Alcoholism.

Jeong Ho Lee1, Chang Seong Kim2, Eun Hui Bae2, Soo Wan Kim2, Seong Kwon Ma2.   

Abstract

A 44-year-old man with chronic alcoholism presented with seizure and loss of consciousness. He was diagnosed with alcoholic hepatic encephalopathy, and his neurologic symptoms recovered after lactulose enema treatment. His initial serum sodium level was 141mEq/L. However, his mental state became confused after treatment with lactulose enema for five days, and his serum sodium level increased to 178mEq/L. After five days of gradual correction of serum sodium level from 178mEq/L to 140mEq/L, the patient's mental state recovered, but motor weakness in both limbs remained. Therefore, magnetic resonance imaging of the brain was performed. T2-weighted brain images showed bilateral symmetrical hyperintensities in the central pons, basal ganglia, thalami, hippocampi and unci, which were consistent with central pontine and extrapontine myelinolysis. We report a rare case of osmotic demyelination syndrome that occurred as a result of a rapid increase from a normal sodium level to hypernatremia caused by lactulose enema administered to treat alcoholic hepatic encephalopathy.
Copyright © 2021 Korean Society for Electrolyte and Blood Pressure Research.

Entities:  

Keywords:  Alcoholic; Central pontine myelinolysis; Extrapontine myelinolysis; Hepatic encephalopathy; Lactulose

Year:  2021        PMID: 34290820      PMCID: PMC8267071          DOI: 10.5049/EBP.2021.19.1.15

Source DB:  PubMed          Journal:  Electrolyte Blood Press        ISSN: 1738-5997


  18 in total

1.  Diffuse demyelinating lesions of the brain after the rapid development of hypernatremia.

Authors:  W R Clark
Journal:  West J Med       Date:  1992-11

2.  Minocycline prevents osmotic demyelination associated with aquaresis.

Authors:  Hiroshi Takagi; Yoshihisa Sugimura; Haruyuki Suzuki; Shintaro Iwama; Hisakazu Izumida; Haruki Fujisawa; Koichiro Ogawa; Kotaro Nakashima; Hiroshi Ochiai; Seiji Takeuchi; Atsushi Kiyota; Hidetaka Suga; Motomitsu Goto; Ryoichi Banno; Hiroshi Arima; Yutaka Oiso
Journal:  Kidney Int       Date:  2014-04-23       Impact factor: 10.612

3.  Minocycline protects against neurologic complications of rapid correction of hyponatremia.

Authors:  Fabrice Gankam-Kengne; Alain Soupart; Roland Pochet; Jean Pierre Brion; Guy Decaux
Journal:  J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 10.121

4.  Wrong idea, good results (the lactulose story).

Authors:  U P Haemmerli; J Bircher
Journal:  N Engl J Med       Date:  1969-08-21       Impact factor: 91.245

5.  Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients.

Authors:  Ramesha Nekkare Kallakatta; Ashalatha Radhakrishnan; R K Fayaz; J P Unnikrishnan; Chandrasekharan Kesavadas; Sankara P Sarma
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-08       Impact factor: 10.154

6.  Protective effect of dexamethasone on osmotic-induced demyelination in rats.

Authors:  Yoshihisa Sugimura; Takashi Murase; Seiko Takefuji; Shizu Hayasaka; Yoshiko Takagishi; Yutaka Oiso; Yoshiharu Murata
Journal:  Exp Neurol       Date:  2005-03       Impact factor: 5.330

7.  Effect of rapid correction of hyponatremia on the blood-brain barrier of rats.

Authors:  S Adler; J G Verbalis; D Williams
Journal:  Brain Res       Date:  1995-05-08       Impact factor: 3.252

8.  Hypernatremia and lactulose therapy.

Authors:  D C Nelson; W R McGrew; A M Hoyumpa
Journal:  JAMA       Date:  1983-03-11       Impact factor: 56.272

9.  Effects of hypernatraemia in the central nervous system and its therapy in rats and rabbits.

Authors:  J C Ayus; D L Armstrong; A I Arieff
Journal:  J Physiol       Date:  1996-04-01       Impact factor: 5.182

10.  The Improvement of the Outcome of Osmotic Demyelination Syndrome by Plasma Exchange.

Authors:  Saeko Kumon; Ryosuke Usui; Shinzo Kuzuhara; Kosaku Nitta; Minako Koike
Journal:  Intern Med       Date:  2017-03-17       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.